|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||74.85 - 74.85|
|52-week range||74.85 - 74.85|
|Beta (5Y monthly)||0.42|
|PE ratio (TTM)||27.03|
|Earnings date||02 Feb 2022 - 07 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Jose Luis Jimenez, University of Colorado at Boulder professor of chemistry and CIRES fellow, joins Yahoo Finance Live to give his expert opinion on where investments in masks and ventilation could aid in lowering COVID transmission rates.
KENILWORTH, N.J., December 03, 2021--FDA Approves KEYTRUDA as Adjuvant Treatment for Adult and Pediatric (Age 12+) Patients With Stage IIB or IIC Melanoma Following Complete Resection
Hennion & Walsh CIO Kevin Mahn joins Yahoo Finance Live to discuss the stock market amid heightened market volatility in recent days.